Enhancing Pharmacist’s Role and Tuberculosis Patient Outcomes Through Training-Education-Monitoring-Adherence-Networking (TEMAN) Pharmacist Model Intervention
Journal Title: Indonesian Journal of Clinical Pharmacy - Year 2017, Vol 6, Issue 4
Abstract
Training-Education-Monitoring-Adherence-Networking (TEMAN) Pharmacist model provides opportunities for trained pharmacist to intervene through education of tuberculosis (TB) patient, therapy monitoring, assessment of patient’s adherence, and collaboration with other health professionals. The study aimed to determine the impact of TEMAN Pharmacist model intervention against the role of pharmacist and TB patient outcomes. The study design was a quasi-experimental study with one group pretest-posttest consisted of two phases: training and pharmacist intervention. After training, pharmacists intervene during regular visits TB patients in primary health care and Special Hospital Lung Respira in Yogyakarta. The research subjects were TB officer (pharmacist and TB programmers) and patients with newly TB diagnostic who met the inclusion criteria, i.e. patients aged 15 years or older, receiving antituberculosis therapy, and willing to fill out given questionnaires and signing a letter of approval for the study (informed consent). Meanwhile, the exclusion criteria were patients with multidrug resistance (MDR) TB; have hepatic disease, psychiatry (mental), and cognitive dysfunction. The instrument developed was a questionnaire to measure the level of knowledge of TB officers and questionnaires to measure the level of knowledge and adherence of TB patients. The data were analyzed descriptively and by using Wilcoxon test. The training effectively improved the knowledge of participants significantly (p=0,000) on average 11.3±3.00 (intermediate category) to 16.3±2.31 (high category). A total of 40 (81.6%) TB patients increased their knowledge significantly (p=0,000) and 5 (10.2%) increased their adherence significantly (p=0,034) after the pharmacist’s intervention. Additionally, out of 49 patients, 29 (59.2%) patients increased body weight, 100% sputum smear conversion, 33 (67.3%) incidence of ADR, and 8 (16.3%) potential drug interactions were documented by the pharmacist monitoring. Intervention of TEMAN Pharmacist model improves the role of the pharmacist and the outcome of TB patients.
Authors and Affiliations
Nanang M. Yasin, Djoko Wahyono, Bambang S. Riyanto, Ika P. Sari
Keywords
Related Articles
- EP ID EP370129
- DOI 10.15416/ijcp.2017.6.4.247
- Views 88
- Downloads 0
Glycemic Control and Prevalence of Chronic Kidney Disease in Type‑2 Diabetes Mellitus Patients at Primary Healthcare Centers in Yogyakarta Province 2015
Good glycemic control in type-2 diabetes mellitus (T2DM) has proven to be able to prevent complications. Primary healthcare is at the forefront being expected to provide good services in T2DM management for preventing su...
Study of AgNOR Value and MIB-1 in Breast Cancer Treated With Surgery
AgNOR and MIB-1 are marker for breast cancer cell proliferation and can be use as based for radiotherapy treatment after surgery. Value of AgNOR and MIB-1 index were determined using staining and immunohistochemistry sta...
Analysis of Knowledge Level and Perception on Singkawang City Community towards Generic Medicines
Survey data show that the use of generic medicines in Indonesia is relatively very small, which only amounted 7%. This is due to lack of knowledge and poor perceptions towards generic medicines. Knowledge level and perce...
Cost of Illness Analysis of Insulin and Insulin-Metformin Combination Usage towards Diabetes Mellitus Type 2 Patients at Hospital in Bandung
Diabetes mellitus (DM) type 2 is a progressive disease that impact on the patients incurred costs during the illness. This study was conducted on May to June at one of hospital in Bandung. This study aimed to obtain cost...
Distribution and Genotypic Analysis of Rubella Virus in West Java on 2011–2013
Rubella spreads around the world and dangerous especially for pregnant women because it can cause abortion, fetal death or congenital rubella syndrome (CRS) almost 90% cases. Spread and identification of rubella genotype...